After Pharma: 8 Section 232 Tariff Deadlines Heading for Your Supply Chain

The 100% tariff on patented pharmaceuticals announced April 2 grabbed the headlines. But it's one of at least fourteen Section 232 actions the administration has launched since March 2025 — and eight investigations with no tariff decision yet have deadlines falling between now and year-end. If you import aircraft parts, wind turbine components, medical devices, drones, polysilicon, critical minerals, trucks, or industrial robots, your clock is already ticking.

On April 2, 2026, President Trump signed a proclamation slapping a 100% ad valorem duty on patented pharmaceutical imports. The industry reacted like it had been blindsided. It shouldn't have been. The Commerce Department investigation behind those tariffs was initiated on April 1, 2025 — a full year earlier. The public comment period closed months ago. The report landed on the President's desk in late December.

Every single Section 232 investigation the administration has completed so far has resulted in tariffs. Steel and aluminum: 50%. Copper: 50%. Timber and lumber: 10% to 50%. Semiconductors: 25%. Pharmaceuticals: 100%.

The pattern is unmistakable. And right now, eight more investigations are marching through the same pipeline — with the first deadlines hitting in less than two weeks.

How the Section 232 Machine Works

Section 232 of the Trade Expansion Act of 1962 authorizes the President to impose tariffs, quotas, or other import restrictions when Commerce determines that imports threaten to impair national security. The process follows a predictable sequence:

1. Commerce initiates an investigation (self-initiated or by petition)
2. A public comment period opens (typically 30-60 days)
3. Commerce delivers a confidential report to the President (within 270 days of initiation)
4. The President has 90 days to act on the report's recommendations

In practice, this administration has moved faster than those statutory timelines suggest. And unlike the International Emergency Economic Powers Act (IEEPA) tariffs — which the Supreme Court struck down in February 2026 — Section 232 tariffs have survived every legal challenge brought against them. The Court of International Trade upheld the steel and aluminum tariffs in 2019, and the Federal Circuit affirmed in 2021. That legal durability is precisely why Section 232 has become the administration's go-to tariff authority.

The 8 Investigations in the Pipeline

Here's what's pending, ordered by when action is most likely:

Three of these have deadlines before the end of May. Five more follow by mid-summer. Every one of them has cleared the public comment phase.

What Each Investigation Targets

Wind Turbines & Components — Report Due May 10

Commerce is examining imports of nacelles, blades, towers, generators, gearboxes, and related components. The United States imported approximately $3.4 billion in wind energy equipment in 2025, with significant volumes from Denmark (Vestas), Spain (Siemens Gamesa), and China (Goldwind, Envision). Products classified under HTS subheadings in chapters 73 (steel towers), 84 (gearboxes, generators), and 85 (electrical components) are potentially in scope. With the report due May 10, a presidential decision could come as early as June.

Commercial Aircraft & Jet Engines — Action Expected Mid-May

This is the investigation with the largest dollar value at stake. The U.S. imported over $60 billion in aircraft and parts in 2025, primarily from the EU (Airbus), Canada, Japan, and the UK. Products in HTS Chapter 88 — complete aircraft, engines, and structural components — are the primary targets. Boeing itself relies on a global supply chain that includes fuselages from Japan, wings from South Korea, and engines assembled across multiple countries. A 25% tariff on aircraft components could reshape commercial aviation economics overnight.

PPE, Medical Equipment & Devices — Report Due May 30

The COVID-19 pandemic exposed deep U.S. dependence on imported personal protective equipment, medical consumables, and diagnostic devices. This investigation covers a sweeping range of products across HTS Chapters 39 (plastic medical components), 40 (rubber gloves), 48 (paper-based medical products), and 90 (optical, medical, and surgical instruments). China accounts for over 70% of U.S. PPE imports. Hospital systems and medical distributors should be watching this one closely.

Critical Minerals — Negotiation Report Due July 13

On January 14, 2026, President Trump issued a proclamation ordering Commerce and USTR to negotiate agreements with trading partners on critical mineral supplies — rather than imposing immediate tariffs. That negotiation window expires July 13. If the administration determines that talks haven't produced adequate commitments, tariffs on processed critical minerals and derivative products (PCMDPs) — including rare earths, lithium, cobalt, graphite, and manganese — could follow quickly. China dominates processing of these minerals, controlling 60-90% of global refined output for many critical materials.

Polysilicon & Derivatives — Action Expected Mid-July

Polysilicon is the foundational material for both semiconductor wafers and solar panels. The investigation covers products classified under HTS Chapter 28 (silicon in various purities) and downstream derivatives. China produces roughly 80% of the world's polysilicon. A tariff here would ripple through both the semiconductor and renewable energy supply chains simultaneously.

Unmanned Aircraft Systems (Drones) — Action Expected Mid-July

DJI, the Shenzhen-based manufacturer, controls an estimated 70% of the global commercial drone market. The investigation covers complete unmanned aircraft systems, their parts and components, and communication systems — spanning HTS Chapters 85 (electronic components) and 88 (aircraft). With DJI already subject to FCC restrictions and a House-passed ban, Section 232 tariffs would add another layer of cost for importers of commercial and enterprise drones.

Trucks — Action Pending

The truck investigation was initiated in April 2025 with a report due by January 2026. That report has likely been delivered, meaning the President could act at any time. Products in HTS Chapter 87 — motor vehicles for the transport of goods — are in scope. This is distinct from the existing 25% Section 232 tariff on passenger automobiles and auto parts.

Robotics & Industrial Machinery — Late 2026

Initiated September 26, 2025, this is the most recent investigation. It covers industrial robots, CNC machines, automation systems, and their parts and components under HTS Chapters 84 and 85. The U.S. Chamber of Commerce filed extensive comments warning that tariffs on imported machinery would undermine the very domestic manufacturing the administration is trying to promote. Japan, Germany, Switzerland, and South Korea are the primary sources. A report is expected by mid-2026 at the earliest, with presidential action likely in late 2026.

The Rate Question: What to Expect

No one outside the administration knows the exact rates these investigations will produce. But the pattern from completed investigations offers a guide:

The range is 10% to 100%, with most landing between 25% and 50%. The administration has also shown a pattern of tiered structures — applying lower rates for allied nations (the UK, EU, Japan, South Korea) and higher rates for China. The pharma proclamation is the most elaborate example: 100% default, 15% for EU/Japan/Korea/Switzerland, 10% for the UK, 20% for companies with onshoring plans, and 0% for companies with MFN pricing deals.

Expect similar tiered frameworks for aircraft, critical minerals, and other high-value product categories where allied supply chains are involved.

Why This Matters for HTS Classification

Section 232 tariffs are applied through additional Chapter 99 HTS headings that reference product-specific subheadings in the base tariff schedule. Getting your classification right has always been important. Now it's the difference between a 0% rate and a 50% rate — or even 100%.

Consider this: the pharmaceutical proclamation covers products under more than 130 HTSUS subheadings spanning Chapters 29 and 30. Products classified under Annex IV codes get a 0% Section 232 rate. Products classified one subheading over get 100%. A single digit in your HTS code could mean a six- or seven-figure duty swing.

The same dynamic will apply to every new Section 232 action. When the wind turbine proclamation drops, some Chapter 84 subheadings will be covered and others won't. When the aircraft tariffs hit, certain Chapter 88 codes will carry new duties while related codes remain clean. Accurate, defensible classification isn't optional anymore — it's your primary duty mitigation tool.

The Stacking Problem

One complexity importers must navigate: how Section 232 tariffs interact with other duty programs. Under the administration's April 2025 executive order addressing tariff "stacking," Section 232 tariffs generally do not stack on top of the Section 122 temporary import surcharge (the 10% global tariff that replaced the struck-down IEEPA duties). However, Section 232 tariffs do stack on top of:

• Column 1 MFN rates (the base tariff schedule)
• Section 301 tariffs (China-specific duties)
• Antidumping and countervailing duties (AD/CVD orders)

So an importer bringing in a covered product from China could face the Column 1 rate, plus Section 301 duties, plus AD/CVD duties, plus a new Section 232 tariff. For some product categories, cumulative rates could exceed 150%.

What Importers Should Do Now

You don't need to wait for the proclamation to start preparing. Here's your action list:

1. Audit your HTS classifications across all eight product categories. If you import anything classified in Chapters 25, 26, 28, 39, 40, 48, 73, 84, 85, 87, 88, or 90, pull your entry data and identify which subheadings could fall within a Section 232 scope. Classification errors discovered during an audit are correctable. Classification errors discovered by CBP during an enforcement action are expensive.

2. Model the financial impact at 25%, 50%, and 100% rates. Run three scenarios for each potentially affected product line. Identify which products remain viable at each rate and which require supply chain changes. Share these models with your finance and procurement teams now — not after the proclamation.

3. Map your country-of-origin exposure. Every Section 232 action so far has included country-specific tiered rates. Products from allied nations consistently get lower rates than products from China. If your supply chain runs through China for any of these eight categories, you should be exploring alternatives in allied jurisdictions immediately.

4. Review your Foreign Trade Zone strategy. Under most Section 232 proclamations, goods admitted to FTZs after the effective date must be classified at admission (privileged foreign status). FTZ operators who have been deferring classification decisions will lose that flexibility.

5. Track the Federal Register. Commerce publishes investigation updates, public hearing notices, and final proclamations in the Federal Register. Subscribe to notifications for BIS docket numbers associated with each investigation you're exposed to.

6. Engage counsel or your customs broker now. Several of these investigations still have open processes for company-specific exemptions, exclusion requests, or negotiated agreements. The pharmaceutical tariffs included 17 named companies with preferential treatment. Future proclamations may offer similar opportunities — but only for companies that engage early.

The Calendar Ahead

The next 90 days will be among the most consequential for U.S. trade policy in decades:

• May 10: Wind turbine investigation report due
• Mid-May: Commercial aircraft tariff action expected
• May 30: PPE and medical equipment report due
• July 1: Commerce update on semiconductor data center tariffs due
• July 13: Critical minerals negotiation report due
• Mid-July: Polysilicon and drone tariff actions expected
• July 24: Section 122 (10% global tariff) scheduled to expire

By the end of summer, the tariff landscape for U.S. importers could look radically different from today. Companies that treated the pharmaceutical tariff as a one-off event are about to discover it was just the opening act.

Staying Ahead of the Wave

The administration has made its Section 232 strategy clear: investigate, report, impose tariffs, and use tiered rates to incentivize onshoring and allied sourcing. Importers who understand this playbook can get ahead of it. Those who wait for each proclamation to react will keep getting caught flat-footed.

Tools like TariffLens can help you monitor your HTS classifications against evolving Section 232 scopes and model duty impacts before they hit your bottom line.

This article is for informational purposes only and does not constitute legal, tax, or customs advice. Consult a licensed customs broker or trade attorney for guidance specific to your situation.